•   
  •  
  •  
  • Login
  • |
  • Register


NGS Leaders Blog

On the Road to the $1,000 Genome

 Permanent link

Davies_pic April 18, 2011                  

 Kevin Davies :  In May, I was privileged to be a guest speaker at the second annual conference on personalized medicine hosted by Larry Gold, professor at the University of Colorado (“CU”) and founder/CEO of protein biomarker company SomaLogic.


The GoldLab symposium brings together an impressively wide variety of speakers discussing trends in all facets of ‘omics research, personalized medicine and healthcare. Gold is an advocate of what he calls “longitudinal ‘omics,” the idea that personal health can (and eventually will) be monitored via a recurring series of simple blood tests using a sophisticated molecular techniques to detect fluctuations in select groups of protein biomarkers that predict the onset of cancer, cardiovascular disease, and many other conditions.


All of the videos from the 2011 GoldLab Symposium are now available on YouTube. Particular standouts in my mind, quite unrelated to next-gen sequencing, include Brandeis University professor Greg Petsko on the coming epidemic of neurological disorders and New York fashion photographer Rick Guidotti’s astonishing work on behalf of an organization called Positive Exposure, instilling extraordinary self-esteem in children with neglected disorders through the power of photography.

 

As for my own talk, with University of Colorado Nobel Laureate Tom Cech in the front row, I thought it only fitting to begin by congratulating the CU faculty and student body for its superb accomplishment in taking prime position in the latest ranking of North American party schools, published in that esteemed journal Playboy. From there, it was best to move on and talk about the technology and pioneers paving the road to the $1,000 genome:

 

 

OCT
10
I-Study: Genomic Interpretation - Who Will Pay?
During this webinar, members of the study review team present preliminary findings of the I-Study, conducted at the Harvard Medical School's 2011 Personalized Medicine Conference.
Twitter Feed
Privacy Policy|Terms of Use